Dynamic spectral imaging colposcopy: higher sensitivity for detection of premalignant cervical lesions

Autor: Ja, Louwers, A, Zaal, M, Kocken, Wa, Ter Harmsel, Gcm, Graziosi, Jwm, Spruijt, J, Berkhof, C, Balas, E, Papagiannakis, Pjf, Snijders, Cjlm, Meijer, Fj, van Kemenade, Rhm, Verheijen

Publikováno v: BJOG : an international journal of obstetrics and gynaecology. 118(3)

to validate the dynamic spectral imaging (DSI) colposcope's colour-coded map in discriminating high- from low-grade cervical lesions and non-neoplastic tissue.prospective, comparative, multicentre clinical trial.the colposcopy clinics of three Dutch

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e99c9e7c7bc61eabdcdf59ff6ee49755
https://pubmed.ncbi.nlm.nih.gov/21176085

LOCALIZATION AND IMAGING OF RADIOLABELED MONOCLONAL-ANTIBODY AGAINST SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK IN TUMOR-BEARING NUDE-MICE

Autor: JJ QUAK, AJM BALM, JGP BRAKKEE, RJ SCHEPER, Hidde Haisma, BJM BRAAKHUIS, CJLM MEIJER, GB SNOW

Publikováno v: International Journal of Cancer, 44(3), 534-538. Wiley
University of Groningen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a6e9fb4fbb4c35331c630344680b5ea7
https://research.rug.nl/en/publications/94066d40-b10c-4164-bf68-6ec0d92d3003

Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesions.

Autor: Louvanto K; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland., Verhoef L; Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Pimenoff V; Unit of Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, CLINTEC, Karolinska Institute, Stockholm, Sweden., Eriksson T; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Leppälä S; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Lagheden C; Unit of Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, CLINTEC, Karolinska Institute, Stockholm, Sweden., Gray P; Unit of Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, CLINTEC, Karolinska Institute, Stockholm, Sweden., Scibior-Bentkowska D; Centre for Cancer Screening, Prevention and Early Detection (SPED), Wolfson Institute of Population Health, Queen Mary University of London, London, UK., Sumiec E; Centre for Cancer Screening, Prevention and Early Detection (SPED), Wolfson Institute of Population Health, Queen Mary University of London, London, UK., Nieminen P; Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Dillner J; Unit of Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, CLINTEC, Karolinska Institute, Stockholm, Sweden., Berkhof J; Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Meijer CJLM; Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Lehtinen M; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Unit of Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, CLINTEC, Karolinska Institute, Stockholm, Sweden., Nedjai B; Centre for Cancer Screening, Prevention and Early Detection (SPED), Wolfson Institute of Population Health, Queen Mary University of London, London, UK., Heideman DAM; Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.

Publikováno v: International journal of cancer [Int J Cancer] 2024 Nov 01; Vol. 155 (9), pp. 1549-1557. Date of Electronic Publication: 2024 May 27.

Colposcopy Referral and CIN3+ Risk of Human Papillomavirus Genotyping Strategies in Cervical Cancer Screening.

Autor: Kroon KR; Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.; Methodology, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands., Bogaards JA; Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.; Methodology, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands., Heideman DAM; Pathology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands., Meijer CJLM; Pathology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.; Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, the Netherlands., Berkhof J; Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.; Methodology, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.

Publikováno v: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2024 Aug 01; Vol. 33 (8), pp. 1037-1045.

Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.

Autor: Verhoef L; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Pathology, De Boelelaan 1117, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Bleeker MCG; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Pathology, De Boelelaan 1117, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Polman N; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Pathology, De Boelelaan 1117, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Steenbergen RDM; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Pathology, De Boelelaan 1117, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Ebisch RMF; Radboud University Medical Center, Obstetrics and Gynecology, 6525 GA, Nijmegen, the Netherlands., Melchers WJG; Radboud University Medical Center, Medical Microbiology, 6525 GA, Nijmegen, the Netherlands., Bekkers RLM; GROW School for Oncology and Developmental Biology, Maastricht University, 6229 ER, Maastricht, the Netherlands.; Catharina Hospital, 5623 EJ, Eindhoven, the Netherlands., Molijn AC; Eurofins NMDL-LCPL, 2280 CA, Rijswijk, the Netherlands., Quint WG; Eurofins NMDL-LCPL, 2280 CA, Rijswijk, the Netherlands., van Kemenade F; Erasmus MC University Medical Center, Pathology, 3015 GD, Rotterdam, the Netherlands., Meijer CJLM; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Pathology, De Boelelaan 1117, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Berkhof J; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Epidemiology and Data Science, De Boelelaan 1117, Amsterdam, The Netherlands., Heideman DAM; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Pathology, De Boelelaan 1117, Amsterdam, The Netherlands. dam.heideman@amsterdamumc.nl.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands. dam.heideman@amsterdamumc.nl.

Publikováno v: British journal of cancer [Br J Cancer] 2023 Jul; Vol. 129 (1), pp. 104-111. Date of Electronic Publication: 2023 Apr 26.